Drug Trial Radar · NCT02497001
A Randomized, Double-Blind, Parallel-Group, 24-Week, Chronic-Dosing, Multi-Center Study to Assess the Efficacy and Safety of PT010, PT003, and PT009 Compared With Symbicort® Turbuhaler® (Kronos)
Last checked: Nov 19, 2026Latest source record: Dec 24, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,902
Actual
Start
Aug 10, 2015
Primary completion
Jan 5, 2018
Study completion Jan 5, 2018
Sponsor
- Lead sponsor
- Pearl Therapeutics, Inc.Industry
- Sponsor type
- Industry
- First posted
- Jul 14, 2015
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 40 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Study to Assess the Efficacy and Safety of PT010, PT003, and PT009 Compared With Symbicort® Turbuhaler® in Subjects with Moderate to Very Severe Chronic Obstructive Pulmonary Disease.
Conditions
- COPD
Interventions
BGF MDI 320/14.4/9.6 μgDrug
Budesonide, Glycopyrronium, and Formoterol Fumarate Inhalation Aerosol (PT010, BGF metered dose inhaler \[MDI\])
GFF MDI (PT003) 14.4/9.6 μgDrug
Glycopyrronium and Formoterol Fumarate Inhalation Aerosol (PT003, GFF MDI)
BFF MDI (PT009) 320/9.6 μgDrug
Budesonide and Formoterol Fumarate Inhalation Aerosol (PT009, BFF MDI)
Symbicort® Turbuhaler® (TBH) Inhalation PowderDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- FEV1 AUC0-4Time frame: at Week 24
- Change From Baseline in Morning Pre-dose Trough FEV1Time frame: at Week 24
Locations
190 sites in 4 countries. Site status is shown where the registry gives one.
Research Site
Andalusia, Alabama
Research Site
Jasper, Alabama
Research Site
Peoria, Arizona
Research Site
Phoenix, Arizona
Research Site
Fullerton, California
Research Site
Gold River, California
Research Site
Poway, California
Research Site
Rolling Hills Estates, California
Research Site
Sacramento, California
Research Site
Clearwater, Florida
Research Site
Miami, Florida
Research Site
Miami, Florida
Research Site
Ormond Beach, Florida
Research Site
Pensacola, Florida
Research Site
Tamarac, Florida
Research Site
Tampa, Florida
Research Site
Winter Park, Florida
Research Site
Dacula, Georgia
Research Site
Norcross, Georgia
Research Site
Rincon, Georgia
Research Site
Edina, Minnesota
Research Site
Minneapolis, Minnesota
Research Site
Minneapolis, Minnesota
Research Site
Woodbury, Minnesota
Research Site
Saint Charles, Missouri
Research Site
St Louis, Missouri
Research Site
Reno, Nevada
Research Site
Albuquerque, New Mexico
Research Site
Charlotte, North Carolina
Research Site
Gastonia, North Carolina
Research Site
Greensboro, North Carolina
Research Site
Hendersonville, North Carolina
Research Site
Mooresville, North Carolina
Research Site
Wilmington, North Carolina
Research Site
Winston-Salem, North Carolina
Research Site
Cincinnati, Ohio
Research Site
Cincinnati, Ohio
Research Site
Cincinnati, Ohio
Research Site
Columbus, Ohio
Research Site
Columbus, Ohio
Showing 40 of 190 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.